RA Capital Management - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 143 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
RA Capital Management ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$18,750,000
+70.5%
1,250,0000.0%1.69%
+34.2%
Q2 2017$11,000,000
+164.2%
1,250,000
+39.0%
1.26%
+193.5%
Q3 2016$4,164,000
-38.3%
899,438
-22.9%
0.43%
-54.0%
Q2 2016$6,751,000
-49.6%
1,165,938
-47.3%
0.94%
-45.4%
Q1 2016$13,383,000
-33.7%
2,212,0360.0%1.71%
-14.4%
Q4 2015$20,196,000
+147.7%
2,212,036
+53.0%
2.00%
+70.7%
Q3 2015$8,152,000
-89.8%
1,445,430
-80.0%
1.17%
-85.5%
Q2 2015$80,072,000
-29.3%
7,220,2090.0%8.05%
-28.4%
Q1 2015$113,213,000
+2.8%
7,220,2090.0%11.24%
-5.1%
Q4 2014$110,179,000
+41.5%
7,220,2090.0%11.84%
+28.7%
Q3 2014$77,870,000
-42.0%
7,220,209
-17.9%
9.20%
-32.2%
Q2 2014$134,243,000
-33.8%
8,791,305
-21.7%
13.57%
-6.7%
Q1 2014$202,895,000
+77.5%
11,222,053
+36.4%
14.55%
+9.3%
Q4 2013$114,277,000
+50.1%
8,227,272
+13.4%
13.31%
+67.5%
Q3 2013$76,139,000
+16.5%
7,258,244
-13.3%
7.95%
-8.3%
Q2 2013$65,355,0008,368,0948.67%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders